• Guidelines

    Recent clinical guidelines from Global Initiative for Asthma, British Thoracic Society, American Thoracic Society, European Respiratory Society and more

  • Disease Burden

    22 million DALYs are lost each year to asthma (Global Asthma Network, 2014) - find out more about the burden of symptomatic asthma

  • Symptom Management

    Long-term symptom management involves maintaining normal activity and reducing risk of future exacerbations - read more

Welcome to the Symptomatic Asthma Learning Zone

This educational resource is for European healthcare professionals involved in the care of patients with asthma. SPIRIVA® Respimat® is approved for use in asthma in the European Union, Japan, USA and many other countries (Boehringer Ingelheim, 2015). The indication varies by country and this educational resource may contain information about medications for which indications may not be approved in your country.

Disease Awareness

Disease Awareness

The Disease Awareness section provides information regarding the impact and assessment of symptomatic asthma as well as potential management strategies.

Treatment Strategy

Treatment Strategy

The Treatment Strategy section contains information on the management of asthma and the available treatment classes as well as links to a number of useful asthma management guidelines.


Login/ Register Maximise Minimise

Alternatively login via